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In November 2010, UNESCO included “Acupuncture and moxibustion aspart of Chinese traditional medicine” on its Representative List of theIntangible Cultural Heritage of Humanity. This article will consider the
challenges of this “patrimonialisation” of Chinese medicine by going over
the discipline’s recent history. Chinese medicine (中醫 – zhongyi ) finds it-
self in a paradoxical situation, compared in practical terms with biomedi-
cine, in perpetual reclassification, and held up for good or for bad reasons.
Its inclusion in the cultural heritage list highlights several problematic is-
sues. The “invention” of “Traditional Chinese Medicine” (TCM) has been un-
derway for more than 50 years. But the ambivalent nature of teaching has
affected its transmission from expert to apprentice, and questions are con-
stantly raised regarding its scientific credentials as well as its clinical and
therapeutic practices. At a time when acupuncture and Chinese pharma-
copoeia are increasingly spreading in Europe, the Americas, and Africa, and
thus form part of the circulation of knowledge and medical know-how,
their acquisition of heritage status marks a new stage in their ceaseless re-
configuration at both national and international levels. Many questions
arise as to the definition of this medicine, its social and cultural construc-
tion, and its complex status in China and abroad. This article’s main point
will be an analysis of texts offered in the national list of masterpieces and
submissions made to UNESCO for inclusion on its list.
Chinese medicine’s recent history, progress,
and debates
Chinese medicine as found in China now is the fruit of a long history, di-
verse political decisions, and a theoretical and practical reconstruction. (1)
After having had an ambiguous status in communist China until Mao Ze-
dong’s death, it began to enjoy special attention and support from the
Ministry of Health from 1980 onwards. Professionalisation of traditional
practitioners was encouraged, and efforts were made (in 1982-1983) to
define structures for teaching (in Chinese medicine institutions) and re-
search (including in hospitals), with Chinese medicine being clearly distin-
guished from biomedicine. For the purpose of teaching, it was decided to
club together a whole series of doctrines and therapeutic practices from
previous eras drawn sometimes from different schools, but all of them
carefully shorn of anything smacking too much of “superstition.” In med-
ical vocabulary, xiyi (西醫 – “Western medicine” ) is set apart from zhongyi.
The word “traditional” (傳統 – chuantong ) is hardly used in China, with the
expressions “TCM” and “Traditional Chinese Medicine” being used outside
the country or in Chinese publications meant for foreigners. (2)
The issue of Chinese medicine’s validity and survival has been raised
since the 1920s. Those favouring a modern public health system unsuc-
cessfully put forward in 1929 a draft law to ban the teaching and practice
of Chinese medicine. Intellectuals such as Guo Moruo and Lu Xun clubbed
it with divination and such other “superstitions” of another age. After
1949, tension persisted between detractors of the system deemed irra-
tional and supporters who held that the discipline represented national
cultural heritage. (3) From 1950 to 1954, things did not go well for Chinese
medicine, which, according to Wang Bin (王斌 ) represented “feudal soci-
ety” (封建社會 – fengjian shehui ). But from 1954 onwards Mao Zedong
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ABSTRACT: In November 2010, UNESCO included “Acupuncture and moxibustion as part of Chinese traditional medicine” on its Representative
List of the Intangible Cultural Heritage of Humanity. Already in 2006, a national list of oral and intangible masterpieces of heritage was drawn
up. Nine of them pertained to medicine and traditional pharmacopoeia. Since then, two other national lists have been compiled, containing
medical elements. This article analyses the challenges of Chinese medicine’s “patrimonialisation” by retracing the discipline’s recent as well
as much older history. Contents of different lists are examined in this perspective. Chinese medicine finds itself in a paradoxical situation,
compared in practical terms with biomedicine, in perpetual reclassification, and held up for good or for bad reasons. Its inclusion in the
cultural heritage list highlights many problematic issues, such as master-disciple transmission, vague teaching methods, questions as to the
scientific nature or otherwise of its practices, and the industrialisation of its pharmacopoeia. In conclusion, questions may be raised over the
link between protection and denaturation throughout the heritage designation process.
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showed more interest in it with the creation of a section for this medicine
in the Health Ministry and then the setting up of a Chinese company to
produce pharmaceuticals ( 中國藥材公司 – Zhongguo yaocai gongsi ) in
March 1955. The first four universities of Chinese medicine opened in 1956
– at Beijing, Chengdu, Shanghai, and Guangzhou. The idea took shape
around then of “unifying Chinese medicine and Western medicine” (中西
醫結合 – Zhongxiyi jiehe ), and then in 1958 came the famous slogan “Chi-
nese medicine and pharmacology are a great treasure” (中國醫藥學是一個
偉大的寶庫 – Zhongguo yiyaoxue shi yi ge weida de baoku ). With this rose
the notion of national “treasure.”
In order to show the “scientificity” of Chinese medicine or at least its ra-
tional character, work was done on the process stretching from diagnostics
to treatment. The concept of “bianzheng lunzhi” (辯證論治 ), (4) which may
be rendered as “syndrome differentiation and discussion of treatments,”
was forged from 1950. Even though it can be easily shown that there is a
continuity between this way of medical reasoning and the pre-1950 texts,
the fact remains that the willingness to build from that time on a group of
doctrines where the determination – amid the forest of clinical symptoms
– of what constituted the real nature of the disease systematically ac-
corded with the treatment adopted, seemed to be a new stage in the es-
tablishment henceforth of Chinese medicine as a competitor to “Western
medicine.”
From an administrative perspective, several decisions sealed the author-
ities’ firm backing for Chinese medicine. For instance, it was included in Ar-
ticle 21 of the 1982 Constitution pertaining to health. In 1988 the Na-
tional Bureau of Chinese Medicine and Pharmacology ( 中醫藥管理局 –
Zhongyiyao guanli ju ) was established. In the 10th Five Year Plan (2000-
2005), it was decided to boost Chinese medicine’s profile in health institu-
tions. (5) Notwithstanding this intention, there was a qualitative and quan-
titative deterioration. China Daily reported on 29 April 2009 that the num-
ber of doctors practising Western medicine stood at about 5.5 million,
whereas there were just 400,000 TCM practitioners, or 20 percent fewer
than 50 years earlier.
It was in this context that some elements of Chinese medicine practices
were included in the national list of intangible heritage, before the accept-
ance of acupuncture and moxibustion on UNESCO’s representative list.
Alongside these developments, however, Chinese medicine’s actual status
in the country has remained fragile. It is threatened by internal factors to
do with standardisation and the break in transmission of knowledge, as
well as by external ones that question its legitimacy.
Standardisation of teaching
Standardisation has affected many domains. The gradual changes
adopted in university teaching since 1956 have led to the replacement of
the master-disciple model with selectivity in the materials handed down
and an abandonment of the reading and study of medical classics in favour
of manuals produced for the new regimen. (6) Students’ intellectual
achievements do not make for familiarity with ancient texts; in 1999, for
instance, the common material for all university graduates was philosophy,
contemporary Chinese, and English, but not classical Chinese. In 2008, it
was estimated that among all courses for Chinese medicine students, the
actual hours devoted to the discipline proper constituted just half of the
total, the rest taken up by Western medicine courses and those common
for all graduates. (7)
Standardisation and industrialisation
In Chinese medicine, prescriptions (方 – fang ) must be adapted to the
patient’s idiosyncrasies. Using a basic formulation, the doctor juggles with
dosages but also removes or adds one (most often) or many drugs in the
composition, trying to best meet the individual characteristics of the
pathological situation being dealt with. Such subtlety in the art of prescrip-
tion becomes very difficult to apply when the doctor no longer has re-
course to medicines prepared on the spot by the pharmacy or by the pa-
tient concerned, but has to rely on pharmaceutical industry products,
which can only be of the standardised kind. This is what is known as man-
ufactured drugs (中成藥 – zhongchengyao ) ready for consumption, which
have since 1992 benefited from protective measures favouring industrial-
isation so long as they respond to various effectiveness criteria. (8) One of
the specificities demanded of Chinese medicine, namely individualisation
of treatments, is thus called into question by the perhaps unavoidable
transformation of the marketing of traditional medicines.
Since the 1990s and in the context of China’s accession to the World
Trade Organisation (WTO), it became imperative to conform to interna-
tional standards (Good Agricultural Practices, GAP) in farm production
conditions, including of plants forming raw material for pharmaceuticals. (9)
This led to the formulation of a document known as “Good Agricultural
Practices for Chinese Crude Drugs” promulgated in 2003 by the Guojia
shipin yaopin jiandu guanli ju (國家食品藥品監督管理局 – State Food and
Drug Administration ), containing 104 criteria for evaluation. They cover
everything from farming environment, cultivation methods, and hygiene
conditions to the qualification of personnel. Its application can only lead
to the exclusion of small producers and, consequently, of the loss of tradi-
tional know-how. In 2004, in fact, 80 percent of the medicinal plants on
the market came from private farmers lacking a vendor status. Moreover,
the high financial cost of obtaining certification can only benefit big indus-
trial producers. (10) However well founded the quality expectations in farm
production, this policy will reduce the diversity of plants used in Chinese
medicine.
A similar phenomenon can be observed with regard to simple drugs (飲
片 – yinpian ), (11) that is, raw materials produced according to traditional
methods of preparation, which are then used – often in combination (12) –
to put together drugs in various galenic forms following a doctor’s pre-
scription. Good Manufacturing Practices (GMP) apply since 2003 to the
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traditional medicine field and have become indispensable for market ac-
cess since 2008. (13) At the start of that year, a mere 200 of the 1,100 reg-
istered companies making drugs had obtained GMP certification. It is likely
that many firms will disappear, lacking the economic means to obtain this
certification.
The issue of knowledge transmission
The knowledge transmission model for Chinese medicine through univer-
sities has shown limitations, and attempts have been underway since the
1990s to reappraise the master-discipline (師徒傳承 – Shitu chuancheng )
teaching model. This is echoed in the major transmission system (living
human treasure, discussed infra) for national elements of intangible cul-
tural heritage. In 1990, as many as 462 “famous and veteran” practicians
and 725 disciples were chosen, (14) and in this way 2,200 students were
trained between 1990 and 2005. However, it should be noted that many
of these students had already been doctors.
In 1999, this situation was formalised with the Ministry of Health’s de-
cree introducing a master-apprentice transmission contract (師承關係合同
– shicheng guanxi hetong ). An equivalent rating with university teaching
became possible, following tests of knowledge. The teacher must be a doc-
tor with more than 15 years of clinical practice. A standard contract was
proposed in 2006. An evaluation is made at the end of three years, and suc-
cessful candidates receive a certificate of aptitude in traditional medicine
through the master-apprentice method. But it does not amount to the title
of physician. (15)
External criticism
While the internal organisation of the practice and teaching of Chinese
medicine might threaten its cohesion, external criticism can also desta-
bilise it. A section of China’s scientific community seems to have little time
for it. In a shocking episode in 2006, Zhang Gongyao (張功耀 ), a professor
at Zhongnan University (中南 ) at Changsha (長沙 ) in Hunan published an
article calling for the abolition of Chinese medicine and pharmacology. (16)
His argument, going over ground already covered in some instances by
modernist opponents of Chinese medicine at the start of the Republican
era, made four points: much of Chinese medicine must be ranged alongside
the quaint and the magical, its ways are less rational than that of biomed-
icine, it uses products drawn from endangered species, and many drugs are
toxic. And the Xinhua News Agency put out an incisive article on 12 Sep-
tember 2006 pointing to the dangers of Chinese medicine, especially the
toxicity of “natural remedies.” Of course, the “opposing camp” reacted
quickly (Xinhua, 19 October 2006); nevertheless, some of these criticisms
did influence the course of Chinese medicine.
The toxicity of some traditional medicines, which has been taken into ac-
count throughout the long history of Chinese medicines, (17) has led to sev-
eral debates over the past two decades, in China and elsewhere. In 1993,
Belgian doctors identified a kind of vine, Aristolochia fangchi (廣仿己 –
guangfangji ), or more specifically, aristolochic acid – nephrotoxic and car-
cinogenic molecule – contained in this plant, as the source of serious
nephropathy cases. This drug was part of the composition of a formula
used in dieting regimes. (18)
In March 2003, a damages claim was lodged in a Chinese court against
the Tongren Tang group (19) by a patient suffering from uraemia, blamed on
the consumption of the company’s product “Gentian pill to drain the liver”
(龍膽瀉肝丸 – longdan xiegan wan ). (20) The claim was rejected, as the con-
sumer had to provide proof establishing the causality link. For a year, more
such claims were lodged and met with similar dismissals. Be that as it may,
this episode signalled a new awareness among Chinese consumers. As in
the West, pharmaceutical products in general are regarded with mixed
feelings of suspicion and expectation of effectiveness without side effects.
Aristolochia manshuriensis was banned in April 2003 by the Guojia shipin
yaopin jiandu guanli ju, while six other medicinal plants of the Aristolochia
family were also banned in August 2004. (21)
This trend had consequences for research into Chinese medicine, which
mainly tends to prove the innocuousness and effectiveness of traditional
drugs. The 1998 administrative regulation of the National Bureau of Chi-
nese Medicine and Pharmacology specified that research on Chinese medi-
cine must be open to evaluation and verification following modern, precise
scientific criteria. Most research projects in this domain focus on molecular
pharmacology and the characterisation and extraction of active ingredi-
ents. For instance, in 2005, the Guojia ziran kexue jijin (國家自然科學基金 –
National Natural Science Foundation of China ), which provides the most
funds to the Chinese Academy of Medical Sciences, (22) backed 173 projects
relating to Chinese medicine and pharmacology. Of these, 75 percent in-
volved clinical observation of the treatment of a disease using a given phar-
maceutical formula and the identification of active ingredients. In a way,
such research could be carried out on any “traditional” medicine anywhere
on earth, since the internal theoretical coherence of the medical system en-
visaged is ignored. (23)
Intangible cultural heritage
It was in this perpetually changing context that the issue of Chinese
medicine’s patrimonialisation emerged in the 2000s, echoing the
theme of UNESCO’s intangible cultural heritage (ICH). Following more
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than ten years’ reflection, the Convention on the Safeguarding of Intan-
gible Cultural Heritage was adopted unanimously on 17 October 2003
by the UNESCO General Conference at its 32nd session. It came into
force on 20 April 2006. (24) As of August 2011, it had 137 states as par-
ties.
“Intangible Cultural Heritage” is rendered in Chinese as fei wuzhi wenhua
yichan (非物質文化遺產 ). (25) UNESCO offers the following definition, in
which the importance attached to the notion of “communities” as custo-
dians is worth noting:
The ‘Intangible Cultural Heritage’ means the practices, representa-
tions, expressions, knowledge, skills – as well as the instruments, ob-
jects, artefacts and cultural spaces associated therewith – that
communities, groups and, in some cases, individuals recognize as
part of their cultural heritage. This intangible cultural heritage,
transmitted from generation to generation, is constantly recreated
by communities and groups in response to their environment, their
interaction with nature and their history, and provides them with a
sense of identity and continuity, thus promoting respect for cultural
diversity and human creativity.
The gradual development of the ICH concept can be traced back to
the 1950s, when “folklore” was deemed to be in the public domain, not
enjoying copyright protection. In 1973, Bolivia asked UNESCO to con-
sider protecting folklore, the idea being that it could be in the state’s
domain. The 1982 World Conference on Cultural Policies in Mexico City
agreed to treat cultural traditions the same as monuments. In 1989, the
“Recommendation on the Safeguarding of Traditional Culture and Folk-
lore” was adopted. Its main aim to promote studies on folklore and en-
hance skills, but the intellectual property aspect was ignored despite
previous discussions with the World Intellectual Property Organisation
(WIPO).
Attention then turned to the notion of intangible cultural heritage, in
recognition of cultural practices and expressions not necessarily at-
tached to a material form, object, frame, and so forth. It must be
stressed that the 2003 Convention included so-called “elite” culture.
ICH is thus not only “popular traditional culture.” This must be borne in
mind with regard to Chinese medicine, the fruit of scholarly work based
on medical practices inherited from elites of yore.
Debates preceding the Convention’s adoption were inspired by the de-
sire to preserve what was initially called traditional and popular culture,
which until the late 1980s meant research into “folklore.” The growing
feeling that globalisation was a threat to cultural diversity drew on pre-
vious experiences with the UNESCO lists of natural sites and monu-
ments to forge the concept of “intangible cultural heritage.”
The large number of activities that may be considered under ICH (oral
traditions, performing art, social practices, rituals and festivals, the
know-how needed for traditional crafts... ), (26) also included “knowledge
and practices concerning nature and the universe”:
This domain includes numerous areas such as traditional ecological
wisdom, indigenous knowledge, knowledge about local fauna and
flora, traditional healing systems, rituals, beliefs, initiatory rites, cos-
mologies, shamanism, possession rites, social organisations, festi-
vals, languages and visual arts. (27)
Categories of Intangible Cultural Heritage
The 2003 Convention defined three major categories of ICH:
- Representative list of the intangible cultural heritage of humanity con-
tains expressions demonstrating the diversity of intangible heritage in
order to raise awareness of their importance. The intergovernmental com-
mittee overseeing ICH included 90 elements in 2008 (previously called
“masterpieces”) and 76 elements in 2009, adding 47 more in 2010.
- List of intangible heritage requiring urgent protection includes elements
that communities concerned and states parties consider as necessitating
urgent measures in order to ensure their transmission. Inclusion on this list
helps mobilise international cooperation and assistance allowing stake-
holders to take adequate protective measures. In 2009, the committee had
included 12 elements, adding four more in 2010.
- Programmes, projects, and activities for safeguarding intangible cultural
heritage. (28) The 2003 Convention also led to the “living human treasures”
programme. These are “persons who possess to a high degree the knowl-
edge and skills required for performing or recreating specific elements of
the intangible cultural heritage.” The programme was meant to encourage
member states to accord official recognition to those carrying on a tradi-
tion and talented practitioners, as well as to ensure transmission of their
know-how to younger generations. The “living human treasures” must be
compared with the Chinese “representative transmitter” ( 傳承人 –
chuancheng ren ) discussed earlier.
China and ICH
The notion of “heritage” does not have the same history in the West and
China. It may be said that Western thought favoured material and monu-
mental aspects of heritage. In Chinese thinking, the authentic search
should go beyond the material and seek out know-how and ability. (29) This
assertion is to be seen in perspective: the emergence of the concept of in-
tangible cultural heritage found great favour in China, which became a
state party to UNESCO’s ICH Convention in August 2004. (30) A programme
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to protect “China’s national and popular culture” was launched in early
2003 by the Ministry of Culture, the Ministry of Finance, the Commission
of Nationalities, and Cultural Federations. (31) From 2004, a vast inventory
work was undertaken, leading to the first official listing of China’s national
heritage in 2006 (518 elements), then the second in 2008 (510 elements),
and a third in 2011 (191 elements); in all, 1,219 elements have been recog-
nised thus far. (32) Apart from drawing up lists and taking actions, such as
declaring a Cultural Heritage Day and holding numerous exhibitions, the
authorities also chose cultural heritage “inheritors,” that is, living treasures,
keeping in mind transmission of know-how. A first list contained 226 in
2007, and a second had 551 in 2008. (33)
Among the elements included in China’s list of intangible cultural heritage,
many pertain to Chinese medicine. They will be examined in greater detail.
Chinese medicine in the national lists of ICH
The 2006 list
The first national heritage list in 2006 (國家名錄 – Guojia minglu ) con-
tained nine elements from the medical domain. The nominations presented
are accessible, with Chinese and English versions. (34) In general, the Chinese
nominations are detailed and expanded, mentioning the title of the medical
works, but these are ignored in the English version, which is clearly meant
for an international public deemed almost totally ignorant of China’s his-
tory and its medicinal systems. We will consider nine of these elements:
1. TCM approach to life and to disease
In Chinese it is Zhongyi shengming yu jibing renzhi fangfa (中醫生命与疾
病認知方法 ) and in English “The perception method of life and disease of
TCM.” The stakeholder is the Chinese Academy of Medical Sciences.
Recalling that Traditional Chinese Medicine ( TCM in English while in Chi-
nese the text merely says zhongyi ) has a more than 2,000 years’ history,
the text sets out in highly simplified terms the conception of disease, noting
basic elements of what may be called Chinese “correlative thinking”: the
Yin-Yang imbalance that lies behind health problems. The causative role of
wuxing 五行 (“five agents,” wood, fire, earth, metal, and water) are set out:
TCM uses a system of inter-relationships between the five elements
to understand how the various processes of the body support and
control each other. Because of these inter-relationships, when one
of the organs and its associated element is out of balance, the other
elements are also affected.
The text then quickly goes over the “ wuyun liuqi 五運六氣 ,” a system
that was highly influential during the Song dynasty. (35)
The theory of directing one’s strength focuses on how various compo-
nents such as astronomy, meteorological phenomena, and climate
would affect health. This theory consists of two parts, five strengths,
and six climatic factors.
Then the zang (spleen, heart, lungs, liver, and kidneys) and fu 腑 (small
intestine, large intestine, gall bladder, bladder, stomach, and san jiao三角 –
"Triple Burner", an invisible metabolising organ in TCM concept) are cited,
with the following explanation:
Each organ is considered to have its own functions, but these func-
tions have a far wider scope than the purely physiological function
described in Western medicine.
While this assertion is not in the nature of evidence, it is one of the topoi
regularly used to explain the different ways of seeing the role of organs in
Chinese and Western medicine. As enunciated here, it would suffice to say
that they cannot be understood because they are insufficiently developed.
Another explanation is given for the triple burner, an organ whose defini-
tion has been debated throughout Chinese history: “A three-part invisible
metabolising organ in TCM concept.” Clearly, this refers to a “formless” (無
形 – wuxing ) organ, (36) one of two conceptions (the other being that san-
jiao “has form”) of this organ. Attention must be paid in this definition to
the term “metabolising,” the scientific connotation of which lends mod-
ernist garb to Chinese medical thinking. The use of the word “metabolism”
began as recently as the 1860s (37) with the development of biochemistry.
At any rate, the term’s use is not insignificant.
After a brief introduction to the role of “meridians,” the text ends by hint-
ing at Chinese medicine’s precarious position:
But because of the influence of Western medicine, there are fewer
people who understand and can pass on this knowledge system.
Therefore, it is in great need of protection and development.
This clearly puts Chinese medicine in a position requiring protective
measures in view of the growing dominance of Western medicine.
2. Chinese medicine’s diagnostic methods.
The Chinese title is Zhongyi zhenfa (中醫診法 ) and in English “Diagnostic
Methods of Chinese Medicine.” The stakeholder is again the Chinese Acad-
emy of Medical Sciences.
A quick look at the Chinese medicinal system’s four major diagnostic
methods (四診 – sizhen ) follows: observation (望 – wang ), auscultation
and olfaction ( 聞 – wen ), interrogation (問 – wen ), and pulse-taking and
palpation (切 – qie ). The main difference between the Chinese and English
versions is that the Chinese one mentions the major texts dealing with the
subject, such as Maijing (脈經 – Pulse Classic ) by Wang Shuhe (王叔和 )
from the third century AD (late Han dynasty). The mention of such works
in the Chinese version lends a historic depth lacking in the English one.
3. Techniques of preparing Chinese medical material
In Chinese it is Zhongyao paozhi jishu (中藥炮製技術 ), and in English
“Technology of processing Chinese materia medica.” The stakeholders are
the Chinese Academy of Medical Sciences and the China Association of
Traditional Chinese Medicine (中國中藥協會 – Zhongguo zhongyao xiehui ).
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The element is quickly presented:
Processing Chinese materia medica means using traditional meth-
ods and technology to create herbal medicine slices. After process-
ing, the medical effects of the medication are improved and the side
effects decrease. Processing is a necessary procedure.
Then follows a succinct narration of the history of drug preparation tech-
niques. The English version merely cites Shennong bencao jing (神農本草經
– The Divine Farmer’s Herb-Root Classic ), from about the first century AD,
and the Bencao gangmu (本草綱目 – Compendium of Materia Medica ) by
Li Shizhen (李時珍 1596 ), while the Chinese one mentions the great classic
Leigong paozhi lun (雷公砲灸論 – Leigong’s Treatise on Drug Preparation ),
a series of texts dating from the fifth century to the Song dynasty. It ends
with a mention of the highly worrying situation as regards drug prepara-
tion know-how:
At present, there are only about 100 people working on processing
materia medica, and the technology is in danger of dying out. Fur-
thermore, some departments haven’t paid enough attention to tra-
ditional processing technology or taken protective measures. There-
fore, the technology of processing Chinese materia medica is in
great need of protection.
Under these conditions, it seemed imperative to submit the nominations
to UNESCO as elements to be included on the ICH list needing urgent pro-
tection.
4. Traditional galenic preparation methods in Chinese
medicine
The Chinese title is Zhongyi chuantong zhiji fangfa (中醫傳統製劑方法 ),
and in English, “The traditional preparation method of Chinese medicine.”
The stakeholders are the Chinese Academy of Medical Sciences and the
China Association of Traditional Chinese Medicine.
Most succinctly, the text presents the main galenic forms used in Chinese
medicine: pills (丸 – wan and 丹 – dan ), powders (散 – san ), pomades (膏
– gao ), and decoctions (湯 – tang ). It is worth noting the hoary antiquity
(Shang dynasty or earlier) of some modes of drug preparation, especially
of 藥酒 – yaojiu , rendered in English as “medicated alcohol,” the “alcohol”
there being rather anachronistic.
5. Acupuncture and moxibustion.
Zhenjiu (針灸 ) in Chinese is rendered in English as “acupuncture.” The
stakeholders are the Chinese Academy of Medical Sciences and the China
Association of Acupuncture and Moxibustion (中國針灸學會 – Zhongguo
zhenjiuxue hui ).
The English text begins with an assertion in an apparent quest for legiti-
mation in the eyes of international observers:
Acupuncture is an important part of Chinese medicine. It was ini-
tially invented as a technique of medical treatment and gradually
became a science.
Following a brief introduction, the text contains a part on acupuncture’s
history and another on Zhenjiu jiayi jing (針灸甲乙經 ) by Huangfu Mi (with
a vulgar error in the English text, “Huang Fumi”) 皇甫謐 (214-282). The text
later led to a more detailed version that helped include acupuncture in
UNESCO’s list in 2010.
6. Techniques for healing fractures in Chinese medicine
Zhongyi zhenggu liaofa (中醫正骨療法 ) is given as “Chinese medicine
bonesetting techniques” in English. The stakeholder is the Chinese Acad-
emy of Medical Sciences.
The short (eight-line) English text notes that accounts existed in antiq-
uity relating to healing bone fractures and use of splints. The use of small
splints (小夾板 – xiaojiaban ) is presented as China’s contribution to global
medicine. The text stresses that such methods are disappearing for eco-
nomic reasons; the slightly longer Chinese text specifies that such tech-
niques are only to be found in ten or so Chinese medicine hospitals.
7. Medicinal culture of the Tongren tang Chinese
pharmacy
Tongren tang zhongyiyao wenhua (同仁堂中醫藥文化 ): In English, “Cul-
ture of the Tong Ren Tang Drugstore.” The stakeholder is the Tongren Tang
company.
The text briefly introduces the famous pharmacy and its products. Ton-
gren Tang’s history is noteworthy. Founded in Beijing by Yue Xianyang (樂
顯揚 ) in 1669, the pharmacy gradually emerged as a veritable industrial
enterprise and is one of the most prestigious instances of pharmacy’s im-
portance in Chinese medicine. It also illustrates the success of a commer-
cial development strategy that was able to draw on close connections to
the central authorities.
It was Yue Fengming (樂風鳴 ), son of Yue Xianyang, who opened the first
shop in 1702, near Qianmen (前門 ) at Dashalan (大柵欄 ), a commercial
district known to be closest to the imperial court. Yue Fengming secured a
medical official’s post and in 1723 became the designated supplier of
medicines to the court. Tongren Tang’s history is in some ways the story of
commercial success shrewdly pursued through imperial patronage. Fires
ravaged the pharmacy in 1753 and 1834, but the firm prospered neverthe-
less: by the late Qing it sought to guard against rivals’ machinations and
by investing in charitable works. In the twentieth century, 34 other phar-
macies with the Tongren Tang brand name opened between 1907 and
1949, all following the traditional model and not imitating the Western
style. In this sense, Tongren Tang symbolises pharmaceuticals “à la chi-
noise.” (38)
8. Medicinal Culture Huqingyu tang Chinese pharmacy
Huqingyu tang zhongyao wenhua (胡慶余堂中藥文化 ): in English, “Cul-
ture of the Hu Qing Yu Tang Drugstore.” The stakeholder is the Huqingyu
Tang Chinese Medicine Museum.
Huqingyu (39) was formed in Hangzhou in 1874 by Hu Xueyan (胡雪岩
1823-1885 ), one of the most famous Chinese businessmen in the late
Qing period. Hu was close to Zuo Zongtang (左宗棠 1812-1885 ), a mili-
tary chief and administrator who took part in quelling the Taiping rebellion
and founded the Fuzhou arsenal (1866). (40) While he was engaged in the
20 c h i n a  p e r s p e c t i v e s •  N o . 2 0 1 1 / 3
39. For a brief account of Huqingyu, see http://fy.folkw.com/view.asp?id=483 (consulted on 23 November
2011).
40. See Jacques Gernet, Le monde chinois (The Chinese world), Paris, Armand Colin, 1999, p. 483.
41. For a good introduction to Tibetan medicine, see Fernand Meyer, Gso-ba rig-pa: Le système médical
tibétain (Tibetan Medical System), Paris, Éditions du CNRS, 1981.
Special feature
silk and tea trade among other activities, Hu Xueyan also produced phar-
maceuticals, which gave rise to the name Huqingyu (in which qingyu in-
vokes yuqing 余慶 , the “joy inherited from virtuous parents”). The beautiful
commercial building that housed the pharmacy was turned into a Chinese
medicine and pharmacopeia museum in 1991. 
Both the English and Chinese texts note that Huqingyu pharmacy, or
rather Hu Xueyan himself, had a commercial attitude based on jieqi (戒欺
– avoiding deception ). It would seem that the stress on such moral recti-
tude in business could have contemporary echoes.
9. Tibetan medicine
In Chinese it is Zang yiyao (藏醫藥 ) and in English “Tibetan medicine and
pharmacopoeia.” The stakeholders are: Lhasa’s northern school of Tibetan
medicine’s mercury cleansing and refining techniques, and Tibetan phar-
macopoeia and herbal preparation techniques of Renqen Changjor, Garzê
prefecture’s southern school of Tibetan medicine and pharmacopoeia.
The rather long text includes a general introduction beginning thus:
Tibetan medicine, one of the world’s oldest ancient medical sys-
tems that began over 2300 years ago, is a mix of science, art, and
philosophy that takes a holistic approach to health care.
Reading the rest of the text, it is difficult to make out Tibetan medicine’s de-
velopment. Tibetan medicine’s basic work, Rgyud-bzhi (“Four Treatises”), is
mentioned only in passing and in the last paragraph, after examining the
North and South Schools. As is well known, Tibetan medicine is made up of
the double influence of India’s Ayurveda and Chinese medicine, something
the text totally ignores. (41) The Chinese version is presented in a much differ-
ent way and highlights techniques of mercury processing in Tibetan medicine.
This is not the place to consider political issues regarding Tibet and China,
but it seems rather improbable that Tibetan medicine would be submitted
to UNESCO for inclusion as an ICH.
The 2008 and 2011 lists
The 2008 national heritage list has eight elements from the medical do-
main: (42)
1. Preparations for “life cultivation” in Chinese medicine ( 中醫養生 –
Zhongyi yangsheng ).
2. Medicinal culture and traditional Chinese pharmacology (傳統中醫藥
文化 – chuantong zhongyiyao wenhua ): texts offered by pharmacies
and pharmaceutical firms.
3. Mongolian medicine and pharmacology (蒙醫藥 – Meng yiyao ).
4. She nationality medicine and pharmacology ( 族醫藥 – Shezu yiyao ).
The She are a minority nationality in Zhejiang and Fujian.
5. Yao nationality medicine and pharmacology (瑤族醫藥 – Yaozu yiyao ).
The Yao are a minority nationality in Guizhou.
6. Miao nationality medicine and pharmacology (苗醫藥 – Miao yiyao ).
The Miao are a minority nationality (Hmong) in southern China’s
mountainous areas.
7. Dong medicine and pharmacology (侗醫藥 – Dong yiyao ). The Dong
are a minority nationality in Yunnan.
8. Hui medicine and pharmacology (回族醫藥 – Huizu yiyao ). The Hui are
a Muslim minority. (43)
Finally, the third list in 2011 (44) included one item: Medicine and pharma-
cology of the Dai (傣醫藥 – Dai yiyao ), a minority nationality in Yunnan.
As is clear, these primarily concern minority nationalities’ medicinal prac-
tices.
Inclusion of acupuncture and moxibustion in
the 2010 ICH list
UNESCO’s Intergovernmental Committee for the Safeguarding of the In-
tangible Cultural Heritage met from 15 to 19 November 2010 in Nairobi,
Kenya. (45) In China’s case, it decided to include three items on the List of
Intangible Cultural Heritage in Need of Urgent Safeguarding :
• Wooden movable type printing;
• Meshrep; (46)
• The watertight-bulkhead technology of Chinese junks.
The committee also decided to include two elements on the Represen-
tative List of the Intangible Cultural Heritage of Humanity :
• Acupuncture and moxibustion in Chinese traditional medicine;
• Peking opera.
• On acupuncture and moxibustion in Traditional Chinese Medicine, the
UNESCO site said: (47)
Acupuncture and moxibustion are forms of traditional Chinese
medicine widely practised in China and also found in regions of
south-east Asia, Europe and the Americas. The theories of acupunc-
ture and moxibustion hold that the human body acts as a small uni-
verse connected by channels, and that by physically stimulating
these channels the practitioner can promote the human body’s self-
regulating functions and bring health to the patient. This stimula-
tion involves the burning of moxa (mugwort) or the insertion of
needles into points on these channels, with the aim to restore the
body’s balance and prevent and treat disease. In acupuncture, nee-
dles are selected according to the individual condition and used to
puncture and stimulate the chosen points. Moxibustion is usually
divided into direct and indirect moxibustion, in which either moxa
cones are placed directly on points or moxa sticks are held and kept
at some distance from the body surface to warm the chosen area.
Moxa cones and sticks are made of dried mugwort leaves. Acupunc-
ture and moxibustion are taught through verbal instruction and
demonstration, transmitted through master-disciple relations or
through members of a clan. Currently, acupuncture and moxibus-
tion are also transmitted through formal academic education.
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Many points are worth noting in the above. First, it is striking that
acupuncture and moxibustion are now being practiced outside China,
contributing to the circulation of know-how in these globalising times.
This international legitimation perhaps has a strategic value for TCM pro-
ponents in China itself, as the discipline’s internal situation sometimes
puts it in a vulnerable state, as noted earlier. Second, it should be noted
that a holistic representation of the human body is attributed to
acupuncture and moxibustion. This would automatically place it in the
“complementary medicine” category, which confronts the dominant bio-
medicine model globally. Finally, the issue of transmission is stressed, in
particular the “master-disciple” model. This links the debates discussed
above to the issue of Chinese medicine’s “standardisation” to university
teaching.
UNESCO’s site also offers a diaporama and a video, as well as a submis-
sion form in English and French, the consent of communities in Chinese
and English, and the decision regarding inclusion in the ICH list. It is inter-
esting that the “Consent of communities” document carries the following
doctors’ signatures: (48)
He Puren (賀普仁 1926- ) (49) was professor of acupuncture and moxibus-
tion at the TCM hospital in Beijing. The author of numerous books and a
specialist in acupuncture linked to the “eight trigrams” (八卦 – bagua ) of
Yijing, He is introduced as “representative successors of acupuncture and
moxibustion” in Traditional Chinese Medicine.
Wang Xuetai (王雪苔 1925-2008 ), Honorary president of the World Fed-
eration of Acupuncture and Moxibustion Societies. (50)
Cheng Xinnong (程莘農 1921- ), “representative successor” and “senior
expert on Chinese medicine,” established successors’ workshops in 2007
and took on 25 apprentices. The National Medical Master Cheng Xinnong
Academic Seminar was held in 2009. (51) Chen is vice-president of the
China Association of Acupuncture and Moxibustion ( 中國針灸學會 –
Zhongguo zhenjiuxue hui ) and author of Zhongguo zhenjiuxue (中國針灸
學 ), or Chinese Acupuncture and Moxibustion in English. (52)
Zhang Jin (張縉 1930- ) is introduced as supervisor and professor for ac-
ademic successors of famous and venerable doctors of Chinese traditional
medicine.
It is still too early to grasp the precise contribution that could follow
from the inclusion of acupuncture and moxibustion on the ICH list. Any in-
clusion implies protective measures submitted in the candidature text. As
for the element discussed here, measures for knowledge transmission and
documentation have been described and budgeted, as UNESCO will pro-
vide funding. (53) Be that as it may, Chinese medicine’s quest for heritage
status may be seen as a defensive reaction to attacks been directed at it
for nearly a century and also as a response to an objective situation in
which it has been losing ground in China’s health landscape. One of the
most insidious dangers for Chinese medicine stems from its having to don
the garb of other medical practices known to be more “scientific,” such as
biomedicine, in order to preserve itself without losing its soul. But respond-
ing to the heritage enticement has larger consequences, leading to Chinese
medicine’s emergence as humanity’s “common good.” As André Chastel
has said: “By disrupting and breaking age-old practices, the global trading
and industrial civilisation helps discover their qualities, which are quickly
classed, rightly or wrongly, in the heritage pantheon.” (54)
z Translated by N. Jayaram
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